ImmunityBio Inc Stock, NASDAQ:IBRX
9920 Jefferson Boulevard, Culver City, California 90232
United States of America
Number of Employees: 171
ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in Culver City, CA.